Page 27 - FBL AR 2019-20
P. 27

Corporate   Statutory  FinanCial
                                                                                        overview  StatementS  StatementS







































            Further, the global animal feed market   to the assets and cash of each other; the   We believe that the consumer mindset,
            presents a multi-year opportunity. We   increased availability of resources now   manufacturing infrastructure as well as
            have already shifted the needle: In FY   provides us with a potential war-chest   research cum product development have
            2016-17, animal feed accounted for around   with which to grow the business in an   made us growth-ready.
            44% of the Vitamin D3 revenues whereas   organic and inorganic manner across   The time has come for Fermenta to deliver.
            this increased to 56% in FY 2019-20. We   the foreseeable future. As an extension
            have seen a CAGR volume growth of 15%   of the right-sizing of our Balance Sheet
            from FY 2014-15 to FY 2019-20 in Human   and monetisable assets, our credit rating
            Vitamin D3 and 10% in Animal Vitamin D3.   strengthened from BBB to A- (long-term   Mr. Sanjay Buch
            During the same period, we have seen a   debt).                      Chairman
            CAGR in value of 20% in Human Vitamin   Some of the potential is already being
            D3 and 23% in Animal Vitamin D3. Besides,   translated into reality: even as we
            the Company is positioning itself as a   increased our manufacturing capacity in
            dependable supplier of quality products   2019, we plan to increase the production
            with excellence in service delivery, offering   capacity by commencing operations at
            a superior price-value proposition.  Sayakha in the near future, broad-basing
            In view of this large opportunity, the   our manufacturing foundation with a
            Company strengthened its Balance Sheet   multi-year perspective. We believe that
            during the last financial year through a   this sustained investment across market
            merger of its parent Company with the   cycles moderates the premium in timing
            objective to reduce costs and enhance   our investments in line with market
            synergy. Each Company will get access   developments.




            What we are





              Positioned as a   Growing focus on   Global         Integrated    Increasingly asset-  Focus on human
             solutions provider  nutraceuticals and   manufacturing   backwards; wider   light   food applications
                                food basket     arrangements      value chain



                                                                                                              25
   22   23   24   25   26   27   28   29   30   31   32